TLX News: Telix and UniQuest to Collaborate on Radiolabelled Immune Targeting Peptide - 27th Oct 2022, 9:44am

[annb0t]

MELBOURNE, Australia, Oct. 27, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a collaboration with UniQuest Pty Ltd (UniQuest), the commercialisation company of The University of Queensland (UQ), to develop a radiolabelled molecule targeting an immune checkpoint protein. The announcement was made at the AusBiotech 2022 national conference, currently being held in Perth, Western Australia. (PRNewsfoto/Telix Pharmaceuticals Limited)

Under the ...

>>> Read more: Telix and UniQuest to Collaborate on Radiolabelled Immune Targeting Peptide